What is Semaglutide?
Semaglutide is an injectable medication used for treating type 2 diabetes and promoting weight loss. It mimics the effects of a hormone called GLP-1 that helps control blood sugar and appetite levels.
Semaglutide works by slowing digestion and preventing the liver from releasing too much glucose into the bloodstream after meals. It also sends signals to the brain to feel fuller sooner, so less food is consumed. The result is better glycemic control and weight reduction.
Key benefits of semaglutide:
- Lowers HbA1c levels (a key marker of long-term blood sugar management)
- Promotes weight loss of around 10-15% on average
- Has a convenient weekly dosing schedule after a gradual ramp-up period
- Causes fewer gastrointestinal side effects than similar GLP-1 drugs
Semaglutide is sold under the brand names Ozempic® and WegovyTM. Ozempic is FDA-approved for treating type 2 diabetes, while Wegovy is specifically approved for chronic weight management.